Shuguang Tan

11PUBLICATIONS
36CO-AUTHORS
Nanotoxicology, health and safetyDiscourse and pragmaticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 03, 2026
Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases.

|May 27, 2026
Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion.

|Jun 05, 2025
An Engineered Soluble Single-Chain TCR Engager for KRAS-G12V Specific Tumor Immunotherapy.

Keke Ma, Jie Wang, Min Jiang

|Jan 28, 2025
T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots.

Jinmin Tian, Bingli Shang, Jianing Zhang

|Oct 12, 2023
KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors.

Dan Lu, Yuan Chen, Min Jiang

|Apr 26, 2023
De novo design of protein interactions with learned surface fingerprints.

Pablo Gainza, Sarah Wehrle, Alexandra Van Hall-Beauvais

Pageof 2

Frequent Collaborators

6 joint publications

George Fu Gao

3 joint publications

Jianxun Qi

2 joint publications

Sheng Yao

1 joint publications

Yan Chai